Based in Canada, Cadex Genomics is a startup.
Cadex Genomics develops blood-based assays for real-time monitoring of therapy effectiveness in stage IV solid tumor cancer patients, enabling faster detection of disease progression than standard imaging methods.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.